WallStreetZenWallStreetZen

NASDAQ: ATRC
Atricure Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ATRC

Based on 9 analysts offering 12 month price targets for Atricure Inc

Min Forecast
$50.00-13.46%
Avg Forecast
$64.11+10.96%
Max Forecast
$70.00+21.15%

Should I buy or sell ATRC stock?

Based on 9 analysts offering ratings for Atricure Inc.

Strong Buy
Strong Buy
5 analysts 55.56%
Buy
2 analysts 22.22%
Hold
2 analysts 22.22%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model "Buy" agrees with analyst consensus with a "Strong Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their ATRC stock forecasts and price targets.

ATRC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-11-04Find Out Why
lockedlocked$00.00+00.00%2026-11-04
lockedlocked$00.00+00.00%2026-11-04
lockedlocked$00.00+00.00%2026-11-04
lockedlocked$00.00+00.00%2026-11-04Find Out Why
Citizens
Bottom 13%
13
BuyMaintains$68.00+17.69%2026-10-21
BTIG
Top 7%
94
Strong BuyMaintains$63.00+9.03%2026-10-12Find out why
Freedom Capital Markets
Top 46%
55
HoldDowngrades$57.00-1.35%2026-10-02
UBS
Top 35%
66
Strong BuyMaintains$50.00-13.46%2026-07-28

1 of 1

Forecast return on equity

Is ATRC forecast to generate an efficient return?

Company
7.11%
Industry
25.2%
Market
159.92%
ATRC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ATRC forecast to generate an efficient return on assets?

Company
5.28%
Industry
18.03%
ATRC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ATRC earnings per share forecast

What is ATRC's earnings per share in the next 3 years based on estimates from 12 analysts?

Avg 1 year Forecast
$0.26-15%
Avg 2 year Forecast
$0.50+67.97%
Avg 3 year Forecast
$0.72+140.6%
ATRC's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

ATRC revenue forecast

What is ATRC's revenue in the next 3 years based on estimates from 12 analysts?

Avg 1 year Forecast
$620.5M+5.2%
Avg 2 year Forecast
$695.9M+17.99%
Avg 3 year Forecast
$783.2M+32.79%
ATRC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ATRC earnings growth forecast

How is ATRC forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
34.37%
Industry
28.74%
Market
32.32%
ATRC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ATRC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ATRC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ATRC revenue growth forecast

How is ATRC forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
9.81%
Industry
7.82%
Market
12.37%
ATRC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ATRC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ATRC vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
ATRC$57.78$64.11+10.96%Strong Buy
WRBY$30.21$35.00+15.86%Buy
XRAY$9.54$11.14+16.80%Hold
LMAT$81.16$105.33+29.78%Buy
KMTS$30.12$32.00+6.24%Strong Buy
View Top Medical Stocks

Atricure Stock Forecast FAQ

Is Atricure Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NASDAQ: ATRC) stock is to Strong Buy ATRC stock.

Out of 9 analysts, 5 (55.56%) are recommending ATRC as a Strong Buy, 2 (22.22%) are recommending ATRC as a Buy, 2 (22.22%) are recommending ATRC as a Hold, 0 (0%) are recommending ATRC as a Sell, and 0 (0%) are recommending ATRC as a Strong Sell.

If you're new to stock investing, here's how to buy Atricure stock.

What is ATRC's earnings growth forecast for 2026-2028?

(NASDAQ: ATRC) Atricure's forecast annual earnings growth rate of 34.37% is forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 28.74%, and it is also forecast to beat the US market's average forecast earnings growth rate of 32.32%.

Atricure's earnings in 2026 is $14,883,000.On average, 12 Wall Street analysts forecast ATRC's earnings for 2026 to be $12,985,182, with the lowest ATRC earnings forecast at $6,487,499, and the highest ATRC earnings forecast at $19,248,623. On average, 12 Wall Street analysts forecast ATRC's earnings for 2027 to be $25,659,738, with the lowest ATRC earnings forecast at $19,762,938, and the highest ATRC earnings forecast at $33,685,090.

In 2028, ATRC is forecast to generate $36,755,704 in earnings, with the lowest earnings forecast at $19,961,535 and the highest earnings forecast at $54,003,081.

What is ATRC's revenue growth forecast for 2026-2028?

(NASDAQ: ATRC) Atricure's forecast annual revenue growth rate of 9.81% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.82%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.37%.

Atricure's revenue in 2026 is $589,803,000.On average, 12 Wall Street analysts forecast ATRC's revenue for 2026 to be $31,595,748,933, with the lowest ATRC revenue forecast at $30,305,887,505, and the highest ATRC revenue forecast at $32,594,334,903. On average, 12 Wall Street analysts forecast ATRC's revenue for 2027 to be $35,436,307,517, with the lowest ATRC revenue forecast at $33,834,801,717, and the highest ATRC revenue forecast at $36,738,390,293.

In 2028, ATRC is forecast to generate $39,881,822,823 in revenue, with the lowest revenue forecast at $37,962,052,754 and the highest revenue forecast at $41,577,025,624.

What is ATRC's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: ATRC) forecast ROA is 5.28%, which is lower than the forecast US Medical Instruments & Supplies industry average of 18.03%.

What is ATRC's Price Target?

According to 9 Wall Street analysts that have issued a 1 year ATRC price target, the average ATRC price target is $64.11, with the highest ATRC stock price forecast at $70.00 and the lowest ATRC stock price forecast at $50.00.

On average, Wall Street analysts predict that Atricure's share price could reach $64.11 by Nov 4, 2027. The average Atricure stock price prediction forecasts a potential upside of 10.96% from the current ATRC share price of $57.78.

What is ATRC's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: ATRC) Atricure's current Earnings Per Share (EPS) is $0.30. On average, analysts forecast that ATRC's EPS will be $0.26 for 2026, with the lowest EPS forecast at $0.13, and the highest EPS forecast at $0.38. On average, analysts forecast that ATRC's EPS will be $0.50 for 2027, with the lowest EPS forecast at $0.39, and the highest EPS forecast at $0.66. In 2028, ATRC's EPS is forecast to hit $0.72 (min: $0.39, max: $1.06).

What is ATRC's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: ATRC) forecast ROE is 7.11%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.